![Adeel Akhlaq Hassan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Adeel Akhlaq Hassan
Keine laufenden Positionen mehr
Karriereverlauf von Adeel Akhlaq Hassan
Ehemalige bekannte Positionen von Adeel Akhlaq Hassan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bristol-Myers Squibb Pakistan Pvt Ltd.
![]() Bristol-Myers Squibb Pakistan Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Bristol-Myers Squibb Pakistan Pvt Ltd. is a Pakistani company that manufactures pharmaceutical products. The company is located in Pakistan. Bristol-Myers Squibb Pakistan was acquired by GSK Plc from Bristol Myers Squibb Co. on December 22, 2008 for $36.50 million. | Corporate Officer/Principal | - | - |
TAISHO PHARMACEUTICAL INDONESIA TBK PT | Finanzdirektor/CFO | 01.01.2009 | - |
Ausbildung von Adeel Akhlaq Hassan
University of Karachi | Undergraduate Degree |
Statistik
International
Indonesien | 2 |
2 | |
Pakistan | 2 |
Operativ
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
PT Taisho Pharmaceutical Indonesia
![]() PT Taisho Pharmaceutical Indonesia Pharmaceuticals: MajorHealth Technology PT Taisho Pharmaceutical Indonesia engages in the development, registration, process, production and sale of chemical, pharmaceutical, and health care products. Its products include Tempra, Analgesic Balm and Theragran-M. The company was founded on July 8, 1970 and is headquartered in Jakarta, Indonesia. | Health Technology |
Bristol-Myers Squibb Pakistan Pvt Ltd.
![]() Bristol-Myers Squibb Pakistan Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Bristol-Myers Squibb Pakistan Pvt Ltd. is a Pakistani company that manufactures pharmaceutical products. The company is located in Pakistan. Bristol-Myers Squibb Pakistan was acquired by GSK Plc from Bristol Myers Squibb Co. on December 22, 2008 for $36.50 million. | Health Technology |
- Börse
- Insiders
- Adeel Akhlaq Hassan
- Erfahrung